The U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to AstraZeneca's rare blood ...

The Food and Drug Administration on Thursday granted accelerated approval to a new ... to gain FDA approval in cancer, and the first in small cell lung cancer. The FDA approved Imdelltra more than ...

(Reuters) - The U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to AstraZeneca's rare blood disorder treatment Soliris. Amgen's drug will be marketed ...

Amgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex biological drugs. The approval comes with a black-box warning about the risk of serious infections ...

the FDA said. had small cell lung cancer. After chemotherapy and immunotherapy, with her cancer still spreading rapidly, she was accepted into the Amgen study and began getting infusions of the ...

Amgen Inc. (NASDAQ:AMGN) has recently been in the news due to its involvement in the promising obesity drug market. Analysts ...

“The FDA’s approval ... scientific officer at drug maker Amgen, said in a company news release. “Imdelltra offers these patients who are in urgent need of new innovative therapies hope ...

(Reuters) -The U.S. Food and Drug Administration approved on Tuesday Amgen’s Bkemv, the first biosimilar to AstraZeneca’s rare blood disorder ... atypical hemolytic uremic syndrome – can cause anemia ...